|
1
|
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
|
Int J Radiat Oncol Biol Phys
|
2009
|
6.11
|
|
2
|
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
|
J Clin Oncol
|
2011
|
4.12
|
|
3
|
The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas.
|
Int J Radiat Oncol Biol Phys
|
2011
|
2.03
|
|
4
|
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.74
|
|
5
|
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
|
J Neurosurg
|
2011
|
1.70
|
|
6
|
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.
|
Neuro Oncol
|
2011
|
1.17
|
|
7
|
Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.14
|
|
8
|
Treatment of five or more brain metastases with stereotactic radiosurgery.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.14
|
|
9
|
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older.
|
Cancer
|
2012
|
1.08
|
|
10
|
Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
|
J Neurooncol
|
2012
|
1.07
|
|
11
|
Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.04
|
|
12
|
Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
|
J Neurosurg Spine
|
2012
|
1.03
|
|
13
|
Multidisciplinary management of colorectal brain metastases: a retrospective study.
|
Cancer
|
2008
|
0.96
|
|
14
|
Primary Ewing's sarcoma of the ethmoid sinus with intracranial and orbital extension: case report and literature review.
|
Am J Otolaryngol
|
2013
|
0.95
|
|
15
|
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.
|
J Neurooncol
|
2013
|
0.94
|
|
16
|
Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area.
|
Neurosurgery
|
2010
|
0.91
|
|
17
|
Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
|
Am J Clin Oncol
|
2015
|
0.90
|
|
18
|
Stereotactic radiosurgical treatment of brain metastases in older patients.
|
Cancer
|
2008
|
0.89
|
|
19
|
Review of cranial radiotherapy-induced vasculopathy.
|
J Neurooncol
|
2015
|
0.88
|
|
20
|
Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
|
J Neurooncol
|
2013
|
0.88
|
|
21
|
Chromosome 1p and 19q deletions in glioblastoma multiforme.
|
Appl Immunohistochem Mol Morphol
|
2009
|
0.88
|
|
22
|
Radiotherapy for prolactin-secreting pituitary tumors.
|
Pituitary
|
2012
|
0.87
|
|
23
|
Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
|
Lung Cancer
|
2012
|
0.87
|
|
24
|
Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.84
|
|
25
|
Review of the treatment of trigeminal neuralgia with gamma knife radiosurgery.
|
Stereotact Funct Neurosurg
|
2008
|
0.84
|
|
26
|
Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.
|
Surg Neurol
|
2008
|
0.84
|
|
27
|
Recurrent or refractory primary central nervous lymphoma: therapeutic considerations.
|
Expert Rev Anticancer Ther
|
2013
|
0.83
|
|
28
|
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.82
|
|
29
|
Stereotactic radiosurgical treatment of brain metastases to the choroid plexus.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.80
|
|
30
|
Calvarial and skull base metastases: expanding the clinical utility of Gamma Knife surgery.
|
J Neurosurg
|
2014
|
0.80
|
|
31
|
Role of Gamma Knife surgery in patients with 5 or more brain metastases.
|
J Neurosurg
|
2012
|
0.80
|
|
32
|
Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.
|
Cancer
|
2011
|
0.79
|
|
33
|
Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective.
|
Neurosurgery
|
2014
|
0.78
|
|
34
|
Extra-CNS metastasis from glioblastoma: a rare clinical entity.
|
Expert Rev Anticancer Ther
|
2015
|
0.77
|
|
35
|
Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes.
|
J Neurosurg
|
2015
|
0.77
|
|
36
|
Management of recurrent brain metastasis after radiosurgery.
|
Prog Neurol Surg
|
2012
|
0.77
|
|
37
|
Primary central nervous system lymphoma in the elderly: the Cleveland clinic experience.
|
Anticancer Res
|
2013
|
0.77
|
|
38
|
331 Association Between Radiation Necrosis and Tumor Biology Following Stereotactic Radiosurgery for Brain Metastasis.
|
Neurosurgery
|
2016
|
0.76
|
|
39
|
Management of brain metastases.
|
Curr Neurol Neurosci Rep
|
2009
|
0.76
|
|
40
|
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
|
J Neurosurg
|
2014
|
0.75
|
|
41
|
In reply to Reiner et al.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.75
|
|
42
|
Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 2: When and How to Use the New Systemic Agents.
|
Oncology (Williston Park)
|
2017
|
0.75
|
|
43
|
Clinical and Radiographic Outcomes From Repeat Whole-brain Radiation Therapy for Brain Metastases in the Age of Stereotactic Radiosurgery.
|
Am J Clin Oncol
|
2016
|
0.75
|
|
44
|
Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 1: Diagnosis, Prognosis, Symptom Control, and Local Treatment.
|
Oncology (Williston Park)
|
2017
|
0.75
|